National Academies Press: OpenBook

The Children's Vaccine Initiative: Continuing Activities (1995)

Chapter: Involving the U.S. Public and Private Sectors in the CVI

« Previous: INTRODUCING AN EFFECTIVE VACCINE
Suggested Citation:"Involving the U.S. Public and Private Sectors in the CVI." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Involving the U.S. Public and Private Sectors in the CVI

INTRODUCTION

Public- and private-sector participants in this workshop heard a number of interesting and, in some cases, provocative presentations. Speakers addressed the role of the United States in the Children ’s Vaccine Initiative (CVI); the implications of the new United Nations Children’s Fund vaccine procurement strategy; the history of and prospects for differential pricing of U.S.-made vaccines; and the transfer of vaccine technology to the developing world. Consensus was neither sought, nor obtained, on any particular point. Still, the level of honest exchange helped to illuminate, if not completely eliminate, certain areas of misunderstanding.

A number of key ideas emerged from the presentations and resulting dialogue. First, the ability of U.S. vaccine manufacturers to rely on multi-tier, or differential, pricing of vaccines will be critical to their participation in the CVI. Second, the development of markets for vaccine in the developing world (through such efforts as the Vaccine Independence Initiative) will make it more likely that U.S. vaccine and biotechnology firms will decide to sell products in these regions. Third, the U.S. Vaccines for Children initiative, because it imposes a price cap on the current set of childhood vaccines administered in the United States, may reduce industry investment in research on new and improved vaccines. Fourth, efforts at vaccine technology transfer often falter because they fail to take into account the needs and capabilities of developing-country manufacturers. Finally, a strengthening of global public-sector vaccine manufacturing capability may be a key ingredient to a comprehensive approach to vaccine technology transfer.

Suggested Citation:"Involving the U.S. Public and Private Sectors in the CVI." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 27
Next: BRINGING CLARITY TO THE CVI VISION »
The Children's Vaccine Initiative: Continuing Activities Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!